Royalty Pharma (RPRX) FCF Payout Ratio (2019 - 2026)
Royalty Pharma (RPRX) posted FCF Payout Ratio of 0.15 for Q1 2026, down 65.6% sequentially from 0.44 in Q4 2025, and up 65.8% YoY from 0.09 in Q1 2025.
Royalty Pharma (RPRX) FCF Payout Ratio (2019 - 2026) Analysis & Trends
Royalty Pharma has reported FCF Payout Ratio for 8 years, with the latest figure at 0.15 in Q1 2026.
- Quarterly FCF Payout Ratio rose 65.8% year-over-year to 0.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.33 (down 36.88% YoY) and the FY2025 annual result came in at 0.21, down 55.52% from the prior year.
- FCF Payout Ratio slipped to 0.15 in Q1 2026 per RPRX's latest filing, from 0.44 in the prior quarter.
- Over five years, FCF Payout Ratio peaked at 0.44 in Q4 2025 and troughed at 0.44 in Q2 2024.
- A 5-year average of 0.05 and a median of 0.08 in 2023 frame the typical range for FCF Payout Ratio.
- The sharpest annual moves came in 2023 and 2024: FCF Payout Ratio jumped 611.91% in 2023, then slumped 881.2% in 2024.
- Over 5 years, FCF Payout Ratio stood at 0.1 in 2022, then tumbled by 202.85% to 0.11 in 2023, then soared by 219.81% to 0.13 in 2024, then surged by 241.26% to 0.44 in 2025, then sank by 65.6% to 0.15 in 2026.
- According to Business Quant data, FCF Payout Ratio over the past three periods registered 0.15, 0.44, and 0.13 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.17 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.07 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.07 |
| Mar 31, 2026 | 0.15 |
| Dec 31, 2025 | 0.44 |
| Sep 30, 2025 | -0.13 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | 0.09 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | -0.06 |
| Jun 30, 2024 | -0.44 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | -0.11 |
| Sep 30, 2023 | 0.25 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.08 |
| Dec 31, 2022 | 0.10 |
| Sep 30, 2022 | -0.05 |
| Jun 30, 2022 | 0.09 |
| Mar 31, 2022 | 0.08 |
| Dec 31, 2021 | -0.72 |
| Sep 30, 2021 | -0.14 |